Ultrafit 37.5mg/325mg Tablet
Marketer
Fizikem Life Sciences
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Ultrafit 37.5mg/325mg Tablet
Combiflex, a 37.5mg/325mg tablet, combines two analgesics to alleviate moderate to severe pain. Dosage and treatment duration for Combiflex should strictly adhere to your physician's instructions. Consumption with or without food is acceptable; however, if stomach discomfort occurs, take it with food. Consistent medication intake is crucial; discontinue use only upon your doctor's recommendation. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are generally mild and transient. Report any rash or allergic reaction promptly. Pregnant women, those planning pregnancy, or breastfeeding individuals should consult their doctor before use.
Uses of Ultrafit 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Ultrafit 37.5mg/325mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ultrafit 37.5mg/325mg Tablets can be consumed with or without food, although consistent daily timing is recommended.
Common Side effects of Ultrafit 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Ultrafit 37.5mg/325mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ultrafit 37.5mg/325mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Ultrafit 37.5mg/325mg Tablet works:
Combifit 37.5mg/325mg tablets combine tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, reduces pain sensation by interrupting pain signals to the brain. Paracetamol's mechanism involves inhibiting the production of pain-inducing chemical messengers.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ultrafit 37.5mg/325mg Tablet and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Ultrafit 37.5mg/325mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The use of Ultrafit 37.5mg/325mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, seek immediate medical attention if the baby exhibits excessive drowsiness, feeding difficulties, respiratory issues, or hypotonia.
DrivingUNSAFE
Taking Ultrafit 37.5mg/325mg tablets might impair your driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should use the 37.5mg/325mg Ultrafit tablet cautiously. Dosage modification may be necessary; physician consultation is recommended.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Ultrafit 37.5mg/325mg tablets, as dose modification may be necessary. Medical advice is recommended. Ultrafit 37.5mg/325mg tablets are contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Ultrafit 37.5mg/325mg Tablet :
Should you forget a dose of Ultrafit 37.5mg/325mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ultrafit 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently